Posted:
12/30/2024, 2:02:40 AM
Location(s):
Massachusetts, United States ⋅ Boston, Massachusetts, United States
Experience Level(s):
Expert or higher ⋅ Senior
Field(s):
AI & Machine Learning
Company Overview:
Abiologics, Inc. is a privately held, early-stage biotechnology company on a mission to make biology better through chemistry. We are pioneering the development of SynteinsTM, a transformational class of macromolecular medicines unlocked by novel synthetic and computational technologies.
Abiologics was founded in Flagship Pioneering’s venture creation engine, where companies such as Moderna Therapeutics (NASDAQ: MRNA) and Generate Biomedicines were conceived and created. Since Flagship’s founding in 2000, the firm has originated and fostered the development of more than 100 scientific ventures resulting in more than 500 issued patents and more than 50 clinical trials for novel therapeutic agents.
Position Summary:
Abiologics, Inc. is seeking an experienced Computational Biology and Machine Learning leader to head computational platform efforts. This role offers a unique opportunity to advance protein design through the integration of non-canonical amino acids, enabling the development of SynteinsTM -- a novel class of macromolecular medicines. The ideal candidate will possess deep expertise in protein design, computational biology, and machine learning, with a proven track record in leading high-performing, multidisciplinary teams.
Key Responsibilities:
Qualifications:
Location: Boston, MA
At Flagship, we recognize there is no perfect candidate. If you have some of the experience listed above but not all, please apply anyway. Experience comes in many forms, skills are transferable, and passion goes a long way. We are dedicated to building diverse and inclusive teams and look forward to learning more about your unique background.
About Flagship Pioneering:
Flagship Pioneering is a bioplatform innovation company that invents and builds platform companies that change the world. We bring together the greatest scientific minds with entrepreneurial company builders and assemble the capital to allow them to take courageous leaps. Those big leaps in human health and sustainability exponentially accelerate scientific progress in areas ranging from cancer detection and treatment to nature-positive agriculture. What sets Flagship apart is our ability to advance biotechnology by uniting life science innovation, company creation, and capital investment under one roof in a way that is largely without precedent. Our scientific founders, entrepreneurial leaders, and professional capital managers are each aligned around an institutionalized process that enables us to innovate and transform for the benefit of people and planet. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture.
Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies, and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies.
Website: https://www.flagshippioneering.com/
Headquarter Location: Cambridge, Massachusetts, United States
Employee Count: 5001-10000
Year Founded: 2000
Industries: Biotechnology ⋅ Business Development ⋅ Finance ⋅ Health Care ⋅ Venture Capital